Editorial

Who, how and what of pathology of soft tissue sarcoma

Salvatore Lorenzo Renne

PDF COI Form Open Access

---

Editorial Commentary

Management of glioblastoma: a perspective from Lithuania

Adomas Bunevicius, Jurgita Usinskiene, Inesa Buneviciene, Ieva Vincerzevskiene

PDF COI Form Open Access

BReast CAncer gene (BRCA): snapshot of the Middle East

Omalkhair Abulkhair, Nagi S. El Saghir

PDF COI Form Open Access

Management of glioblastoma: an Australian perspective

Hao-Wen Sim, Anna K. Nowak, Zarnie Lwin, Mustafa Khasraw

PDF COI Form Open Access

Management of glioblastoma: a perspective from Nigeria

James A. Balogun, Adefisayo A. Adekanmbi

PDF COI Form Open Access

---

Review Article

The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results

Lauren S. Singer, Alexander Z. Feldman, Robin A. Buerki, Craig M. Horbinski, Rimas V. Lukas, Roger Stupp

PDF COI Form Open Access

Is enhancing recovery after pancreatic cancer surgery even possible?

Monish Karunakaran, Savio George Barreto

PDF Reporting Checklist COI Form Open Access

Integrating PARP inhibitors into the management of breast cancer: where are we?

Hamdy A. Azim, Loay Kassem, Hatem Azim Jr

PDF COI Form Open Access

Management of glioblastoma: a perspective from Mexico

Sergio Moreno-Jiménez, Marco A. Alegría-Loyola, Adam M. Sonabend, Sofia K. Romano, Carlos G. Romo

PDF COI Form Open Access

Anti-angiogenic therapies in the management of glioblastoma

Jessica D. Schulte, Manish K. Aghi, Jennie W. Taylor

PDF COI Form Open Access

Tumor treating fields in neuro-oncology: integration of alternating electric fields therapy into promising treatment strategies

Tamar R. Berger, Eric T. Wong

PDF COI Form Open Access

A view of the epidemiologic landscape: how population-based studies can lend novel insights regarding the pathophysiology of glioblastoma

Ramya Tadipatri, Kristopher Lyon, Amir Azadi, Ekokobe Fonkem

PDF COI Form Open Access

---